Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» US will still pay at least twice as much after negotiating drug prices
US will still pay at least twice as much after negotiating drug prices
US will still pay at least twice as much after negotiating drug prices
Submitted by
admin
on September 3, 2024 - 11:21am
Source:
Reuters
News Tags:
drug pricing
Inflation Reduction Act
Medicare
Headline:
US will still pay at least twice as much after negotiating drug prices
snippet:
U.S. pays higher drug prices, gets priority access
Medicare's negotiated prices most significant for drugs with little competition
Goal is to balance affordability and innovation
Do Not Allow Advertisers to Use My Personal information
